ANIX (Anixa Biosciences) Net Margin %: 0.00% (As of Apr. 2026)


ANIX Anixa Biosciences Inc ANIX
27 GF Score
Price $2.64
! 3 Warning Signs
View Full Analysis

What is Anixa Biosciences Net Margin %?

Anixa Biosciences ANIX -2.60% 27 Net Margin % is 0.00% as of Apr. 2026. GuruFocus rates ANIX with a GF Score™ of 27/100. The stock has 3 warning signs investors should review. Among 946 Biotechnology companies, Anixa Biosciences ranks worse than 105708.14% on this metric.

Net margin is calculated as Net Income divided by its Revenue. Anixa Biosciences's Net Income for the three months ended in Apr. 2026 was $-2.52 Mil. Anixa Biosciences's Revenue for the three months ended in Apr. 2026 was $0.00 Mil. Therefore, Anixa Biosciences's net margin for the quarter that ended in Apr. 2026 was 0.00%.

The historical rank and industry rank for Anixa Biosciences's Net Margin % or its related term are showing as below:


ANIX's Net Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -88.815
* Ranked among companies with meaningful Net Margin % only.

Anixa Biosciences  (NAS:ANIX) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Anixa Biosciences Net Margin % Related Terms

Anixa Biosciences Net Margin % Historical Data

* Premium members only.

The historical data trend for Anixa Biosciences's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Anixa Biosciences Net Margin % Chart

Anixa Biosciences Annual Data
Trend Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24 Oct25
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2,530.08 0.00 -4,671.90 0.00 0.00

Anixa Biosciences Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

ANIX vs PYPD, LONA, SGMO: Net Margin % Comparison

For the Biotechnology subindustry, Anixa Biosciences's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Anixa Biosciences Net Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Anixa Biosciences's Net Margin % distribution charts can be found below:

* The bar in red indicates where Anixa Biosciences's Net Margin % falls into.


ANIX
27GF Score
Anixa Biosciences Inc ANIX
Net Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Anixa Biosciences Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Anixa Biosciences's Net Margin for the fiscal year that ended in Oct. 2025 is calculated as

Net Margin=Net Income (A: Oct. 2025 )/Revenue (A: Oct. 2025 )
=-10.927/0
= %

Anixa Biosciences's Net Margin for the quarter that ended in Apr. 2026 is calculated as

Net Margin=Net Income (Q: Apr. 2026 )/Revenue (Q: Apr. 2026 )
=-2.516/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of 0.00% mean?
Anixa Biosciences (ANIX) has a Net Margin % of 0.00% as of Apr. 2026. Net margin is the ratio of total net income to net sales. View historical data on Anixa Biosciences and its competitors. According to the industry distribution chart, Anixa Biosciences ranks #999999 out of 946 companies in the Biotechnology industry.
Is Anixa Biosciences' Net Margin % too high?
Anixa Biosciences' current Net Margin % is 0.00%. Based on the distribution chart, Anixa Biosciences ranks #999999 out of 946 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Anixa Biosciences has a GF Score™ of 27/100, reflecting its overall financial health beyond just this single metric.
How does Anixa Biosciences' Net Margin % compare to PYPD and LONA?
According to the Biotechnology industry distribution chart, Anixa Biosciences ranks #999999 out of 946 companies for Net Margin %. This places Anixa Biosciences in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Biotechnology company?
A good Net Margin % depends on the Biotechnology industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Anixa Biosciences and its competitors. Anixa Biosciences's current Net Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Anixa Biosciences stock overvalued right now?
Anixa Biosciences (ANIX) has a current Net Margin % of 0.00%. The current Net Margin % is 0.00%. Anixa Biosciences' overall GF Score™ is 27/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Anixa Biosciences (ANIX), the current Net Margin % is 0.00% as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Anixa Biosciences Business Description

Other Exchanges CY71:Germany
Address 3150 Almaden Expressway, Suite 250, San Jose, CA, USA, 95118
Anixa Biosciences Inc is a biotechnology company developing therapies and vaccines focused on critical unmet needs in oncology. Its operations are organized into reportable segments comprising Cancer Vaccines, CAR-T Therapies, and Other. The Cancer Vaccines segment involves vaccines to treat and prevent breast and ovarian cancer, as well as additional cancer vaccines targeting intractable cancers, including high-incidence malignancies in lung, colon, and prostate. The CAR-T Therapies segment involves the development of liraltagene autoleucel (lira-cel), an ovarian cancer immunotherapy using chimeric endocrine receptor-T cell technology, developed at its subsidiary, Certainty Therapeutics, Inc. The Other segment consists of legacy operations, including limited patent licensing activities.
27GF Score

Get the complete analysis for ANIX

Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.64
Price